NASDAQ: $SNY A New Era for Type 1 Diabetes Treatment In a significant milestone for medical science, the FDA has officially approved Tzield (teplizumab-mzwv). This approval marks the introduction of the first-ever disease-modifying therapy for individuals at risk of developing clinical stage 3 Type 1 diabetes. Understanding the Breakthrough For decades, treatment for Type 1…